Skip to content

DR. M. MATTHEUSSEN

Active
Private limited companyfounded 2005active for 21 yearsVenusstraat 17, 2830 Willebroek, BelgiumKBO/BCE: BE 0871.545.790

From the official registers: KBO 20 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. M. MATTHEUSSEN has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €500,578 and a net result of €177,411. Equity has been growing by about 44% per year since 2019. Its solvency ranks better than 83% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. M. MATTHEUSSENActiveChecked score 96/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 26-01-2005 Normal situation
Legal form
Private limited company
Registered office
Venusstraat 17, 2830 Willebroek
Activity
Specialist medical practice NACE 86220
Establishment unit
2.192.439.134 2830 Willebroek, since 26-01-2005
Financial year end
30 June
Peppol
Reachable since 27-03-2026
Company details

Board and ownership

Board
  • Mattheussen MariaDirector
Board & ownership

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€250,047
▲ 37.9%
Turnover
≈ €390,000
estimated
Profit
€177,411
▲ 41.2%
Equity
€500,578
▲ 54.9%
Total assets
€560,679
▲ 49.6%
2025 accounts filed 43 days before the deadline
Filed on 19-12-2025PDF
Financials
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €560,679Equity €500,578 (89.3% of total assets)Figures for financial year 2025 (filed on 23-12-2025)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 72% of micro companies in human health (NACE 86)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 100=
equity 89.3% of total assets
Liquidity 64-16
short-term debt 10.7% · cash 11.4%
Profitability 100=
return on assets 31.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 9.28 (7.16 in 2024), above the usual 1.5. Short-term debt is 10.7% and cash 11.4% of total assets. 10.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 43% on liquidity, 80% on profitability and 81% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €560,679
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €500,578 (89.3% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 23-12-2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 19-12-2025, 43 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
43 days early
2024
on the day
2023
on the day
2022
4 days early
2021
40 days early
2020
46 days early
2019
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 22 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 27 January (4 of the last 5 filed years within 36 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end01-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 85% of companies in human healthsector median €60,139 · 20,665 companies €177,411 View
  • Positive: Equity rose in 2025from €323,168 to €500,578 ▲ 54.9% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €177,411 7 years View

Documents

Annual accounts at the NBB

All 20 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about DR. M. MATTHEUSSEN

What is the company number of DR. M. MATTHEUSSEN?
The company number of DR. M. MATTHEUSSEN is 0871.545.790. The VAT number is the same number with BE in front: BE 0871.545.790.
Where is DR. M. MATTHEUSSEN based?
The registered office is at Venusstraat 17, 2830 Willebroek.Company details
What does DR. M. MATTHEUSSEN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. M. MATTHEUSSEN?
The legal form of DR. M. MATTHEUSSEN is Private limited company (BV).
When was DR. M. MATTHEUSSEN founded?
DR. M. MATTHEUSSEN was founded on 26-01-2005.
Is DR. M. MATTHEUSSEN still active?
Yes, DR. M. MATTHEUSSEN is an active enterprise in the KBO register.
What is the turnover of DR. M. MATTHEUSSEN?
The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €250,047 and 36 comparable companies (NACE 862). It probably lies between €350,000 and €480,000.Financials
Is DR. M. MATTHEUSSEN profitable?
In financial year 2025, DR. M. MATTHEUSSEN made a profit of €177,411.
Where can I find the annual accounts of DR. M. MATTHEUSSEN?
DR. M. MATTHEUSSEN filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of DR. M. MATTHEUSSEN due?
DR. M. MATTHEUSSEN must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Comparable companies

These companies have the same main activity as DR. M. MATTHEUSSEN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €528,000 and €629,000, founded between 2004 and 2007.

CompanyTotal assetsGross margin
DR. M. MATTHEUSSEN Willebroek€560,679€250,047
Dokter Simoens Marc Antwerpen€595,049€256,613
Dokter E. LOQUET Zandhoven€550,979€236,247
DR. Pieter D'Hooge Kapellen€573,307€237,390
Dokters Coenen & Van Laere Mechelen€553,457€225,267
Dr. Stefanie Bosselaers Putte€628,988€237,401
DOKTER VAN BIJSTERVELD SANDOR, HUISARTS Waasmunster€527,811€237,606
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure